Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University College, London
With
Medical Research Council
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥16 years
Underlying haematological malignancy
Planned allogeneic peripheral blood stem cell transplantation from a 10/10 or 9/10 HLA matched unrelated donor, using an Alemtuzumab-based conditioning protocol
Written Informed consent
You may not be if
Life expectancy \< 6 weeks
Female patients who are pregnant and lactating
Patients who are serologically positive for Hepatitis B, C or HIV pre-SCT
Clareo Health | Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)
